Business
Renalytix to Report Financial Results for Q3
Renalytix to Report Financial Results for Q3.
About this update from Renalytix Plc
[{"type":"text","content":"\n \n \n \n \n \n \n \n \n \n \n Renalytix to Report Financial Results for Third Quarter Fiscal 2022 on June 30\n \n \n \n \n \n NEW YORK and SALT LAKE CITY, June 23, 2022 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced the Company will report its third quarter fiscal 2022 financial results on Thursday, June 30, 2022, before market open. The Company will host a corresponding conference call and live webcast to discuss the financial results and key topics including business strategy, partnerships and regulatory and reimbursement processes, at 8:30 a.m. (ET) / 1:30 p.m. (GMT).\n \n \n Conference Call Details:\n \nUS/Canada Participant Toll-Free Dial-In Number: (833) 614-1551\nUS/Canada Participant International Dial-In Number: (914) 987-7290\nUnited Kingdom International Dial-In Number: 0800 0288 438\nUnited Kingdom Local Dial-In Number: 0203 1070 289\nConference ID: 1546327\n \n \n Webcast Registration link: \n https://edge.media-server.com/mmc/p/y3zwhkuk\n \n \n \n For further information, please contact:\n \n \n \n \n \n \n \n \n \n \n Renalytix plc \n \n \n \n \n \n www.renalytix.com\n \n \n \n \n \n \n James McCullough, CEO\n \n \n \n \n \n Via Walbrook PR\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Stifel (Nominated Adviser,\n \n \n Joint Broker\n \n \n )\n \n \n \n \n \n \n Tel: 020 7710 7600\n \n \n \n \n \n \n \n Alex Price /\n Nicholas Moore\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Investec Bank plc (Joint Broker)\n \n \n \n \n \n \n Tel: 020 7597 4000\n \n \n \n \n \n \n \n Gary Clarence / Daniel Adams\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Walbrook PR Limited\n \n \n \n \n \n \n Tel: 020 7933 8780\n \n or \n \n [email protected]\n \n \n \n \n \n \n \n Paul McManus / Lianne Applegarth / Alice Woodings\n \n \n \n \n Mob: 07980 541 893 / 07584 391 303 / 07407 804 654\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n CapComm Partners\n \n \n \n \n Tel: 415-389-6400 or [email protected]\n \n \n \n \n Peter DeNardo\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n About Renalytix\n \n \n Renalytix (LSE: RENX) (NASDAQ: RNLX) is the global found...